bucetin

Known as: beta-hydroxybutyric acid-p-phenetidide, N-(4-ethoxyphenyl)-3-hydroxybutanamide, NHB-PPT 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1966-2017
01219662017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Schistosomiasis is a world health problem, and praziquantel is the only drug currently used for the treatment. There is some… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2012
2012
BACKGROUND Little evidence exists regarding parameter selection for hypoalgesia using interferential therapy (IFT). OBJECTIVE… (More)
Is this relevant?
2004
2004
Our aim was to test whether alpha fetoprotein (AFP) might serve as a marker of hepatic immaturity sufficient to predict an… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Objective: To determine whether heparin bonding reduces the incidence of catheter-related thrombosis and infection in critically… (More)
Is this relevant?
1996
1996
The carcinogenic potential of eight different compounds was assayed in a new medium-term carcinogenicity bioassay using D… (More)
Is this relevant?
1987
1987
The carcinogenicity of bucetin [(3-hydroxy-p-butyrophenetidide) CAS: 1083-57-4], an antipyretic analgesic drug, was examined in… (More)
Is this relevant?
1986
1986
Our data show that 1% of patients who required hospital treatment did so due to severe adverse reactions to analgesics. The most… (More)
Is this relevant?
1981
1981
A thin-layer chromatographic method was developed to analyze phenacetin, 4-amino-phenazone and N-methyl-4-aminophenazone (5 and 1… (More)
Is this relevant?
1978
1978
In our studies with drug combinations, we search for mixtures which would enhance the effectiveness of the related active… (More)
Is this relevant?